ClinicalTrials.gov: Other terms: heart disease | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: heart disease | First posted in the last 14 days
May 12, 2026
Conditions: Stress; Dementia; Cognitive Impairment
Interventions: Behavioral: Live music therapy; Behavioral: Virtual music therapy
Sponsors: University of Pennsylvania; Conestoga High School
Completed
May 12, 2026
Conditions: Acute Kidney Failure; Renal Replacement Therapy for Acute Kidney Injury in ICU; Sedation in Intensive Care Unit Patients; Sedation in the ICU; Sedation in Intensive Care; Blood Pressure; Mean Arterial Pressure Targets; Temperature; Fever; Resuscitated Sudden Cardiac Death; Out of Hospital Cardiac Arrest; Cardiac Arrest (CA)
Interventions: Device: Feedback-controlled temperature device; Other: High MAP; Other: Deep sedation; Other: Fever control without a device; Other: Low MAP; Other: Minimal sedation
Sponsors: Helsinki University Central Hospital
Recruiting
May 12, 2026
Conditions: Healthy Subjects (HS); Elderly Participants; Obese Adult Participants at Risk of Cardiovascular Disease
Interventions: Drug: ISM8969 tablets or placebo; Drug: ISM8969 tablets or placebo; Drug: ISM8969 tablets or placebo
Sponsors: InSilico Medicine Hong Kong Limited
Not yet recruiting
May 12, 2026
Conditions: Bilateral Carpal Tunnel Syndrome (Diagnosis); Cardiac Amyloidosis
Interventions: Diagnostic Test: Technetium-99m Pyrophosphate (Tc-99m PYP) Scan
Sponsors: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Not yet recruiting
May 12, 2026
Conditions: Dystrophinopathy; Muscular Dystrophies; Congenital Myopathies
Interventions: Device: Dual-task cycling; Other: Standard therapy
Sponsors: Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato; IRCCS National Neurological Institute "C. Mondino" Foundation; IRCCS Eugenio Medea; Fondazione Don Carlo Gnocchi Onlus; IRCCS Fondazione Stella Maris
Not yet recruiting
May 12, 2026
Conditions: Heart Failure
Interventions: Behavioral: high-intensity interval training
Sponsors: Chang Gung Memorial Hospital
Completed
May 12, 2026
Conditions: Cardiovascular Health
Interventions: Behavioral: Culturally-adapted intervention to improve cardiovascular health in American Indian women
Sponsors: University of North Carolina, Chapel Hill; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
May 12, 2026
Conditions: Ischemic Heart Disease; Coronary Artery Stenosis; Stable Angina Pectoris; Acute Coronary Syndromes
Interventions: Diagnostic Test: single-channel electrocardiogram
Sponsors: I.M. Sechenov First Moscow State Medical University
Not yet recruiting
May 12, 2026
Conditions: HIV Infections
Interventions: Drug: JL18008 20 μg/kg; Drug: Placebo (for 20 μg/kg Group); Drug: JL18008 40 μg/kg; Drug: Placebo (for 40 μg/kg Group); Drug: JL18008 70 μg/kg; Drug: Placebo (for 70 μg/kg Group)
Sponsors: Jecho Biopharmaceuticals Co., Ltd.
Not yet recruiting
May 12, 2026
Conditions: Mobile Health Apps; Lifestyle Intervention; Prevention; Multi-component Based Behavioral Intervention
Interventions: Behavioral: Multi-component lifestyle intervention
Sponsors: Fangbiao Tao
Not yet recruiting
May 12, 2026
Conditions: Dermatitis, Atopic
Sponsors: Kang Stem Biotech Co., Ltd.
Active, not recruiting
May 12, 2026
Conditions: Uterine Hemorrhage
Interventions: Device: Aqua Therapeutics Thermal Therapy Vapor Ablation System (ATTTVAS)
Sponsors: Aqua Therapeutics, Inc.
Completed
May 12, 2026
Conditions: Acute Myeloid Leukemia With Complex Karyotype; Myelodysplastic Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Myelodysplastic Chronic Myelomonocytic Leukemia; Recurrent Myelodysplastic Syndrome; Recurrent Secondary Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia; Refractory Myelodysplastic Chronic Myelomonocytic Leukemia; Refractory Myelodysplastic Syndrome; Refractory Secondary Acute Myeloid Leukemia
Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Biopsy; Procedure: Computed Tomography; Procedure: Echocardiography Test; Drug: Fludarabine Phosphate; Drug: Melphalan; Procedure: Multigated Acquisition Scan; Biological: Palifermin; Procedure: Peripheral Blood Stem Cell Transplantation; Other: Questionnaire Administration; Drug: Sirolimus; Drug: Tacrolimus; Radiation: Total Marrow and Lymphoid Irradiation
Sponsors: City of Hope Medical Center; National Cancer Institute (NCI)
Not yet recruiting
May 12, 2026
Conditions: Hypercholesterolemia; Atherosclerotic Cardiovascular Disease (ASCVD)
Interventions: Drug: Inclisiran; Drug: Alirocumab
Sponsors: University Medical Centre Ljubljana
Not yet recruiting
May 12, 2026
Conditions: AD - Alzheimer's Disease; MCI
Interventions: Drug: [18F]Flortaucipir Injection
Sponsors: Eli Radiopharma
Recruiting
May 12, 2026
Conditions: Pulmonary Disease, Chronic Obstructive (COPD)
Interventions: Other: Structured Energy Conservation Techniques Training
Sponsors: Akdeniz University
Not yet recruiting
May 12, 2026
Conditions: Intensive Care (ICU); Respiratory Distress Syndrome (RDS); Sedation and Analgesia; Extracorporeal Membrane Oxygenation; Sedation for Mechanical Ventilation; Cardiogenic Shock; Opioid Analgesia; Analgesia
Interventions: Other: Sedation protocol
Sponsors: Guy's and St Thomas' NHS Foundation Trust; King's College London
Not yet recruiting
May 12, 2026
Conditions: Atrial Fibrillation; Atrial Arrhythmia
Interventions: Other: Data collection
Sponsors: University of Chicago; Rush University
Completed
May 12, 2026
Conditions: Heart Failure; Chronic Heart Failure (CHF)
Interventions: Behavioral: RE-AIM-informed autonomy-competence intervention
Sponsors: Universiti Putra Malaysia
Not yet recruiting
May 12, 2026
Conditions: Hypertension (HTN); Hypertension; Blood Pressure, High
Sponsors: Vivek Bhalla; Idorsia Pharmaceuticals Ltd.; Duke University Medical Center, Durham, NC
Not yet recruiting
May 12, 2026
Conditions: Early Risk Screening for Sleep Disordered Breathing in a Dental Setting; Sleep Disordered Breathing (SDB); Obstructive Sleep Apnea (OSA)
Interventions: Device: SleepImage Ring
Sponsors: University of North Carolina, Chapel Hill
Not yet recruiting
May 12, 2026
Conditions: Extracorporeal Membrane Oxygenation Complication; Hemorrhage; Blood Platelet Disorder; Thrombosis
Interventions: Other: blood draws
Sponsors: University Hospital, Toulouse
Not yet recruiting
May 12, 2026
Conditions: Atrial Fibrillation (AF)
Interventions: Device: Identifying extra-PV SRG sites
Sponsors: Anat Milman
Not yet recruiting
May 12, 2026
Conditions: Pediatric Anesthesia; Preoperative Anxiety; Emergence Agitation
Interventions: Drug: Dexmedetomidine; Drug: Midazolam
Sponsors: Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Recruiting
May 12, 2026
Conditions: Vascular Malformations
Interventions: Drug: Bleomycin Sulfate
Sponsors: Institute of Oncology Ljubljana; University Medical Centre Ljubljana
Not yet recruiting
May 12, 2026
Conditions: B-All; Acute Lymphoblastic Leukemia
Interventions: Biological: TSLPR-CART; Drug: Cyclophosphamide; Drug: Fludarabine
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
May 12, 2026
Conditions: Psoriatic Arthritis; Osteoarthitis; Knee; Diabetes (DM); Type 2 Diabetes Mellitus (T2DM); Obesity (Disorder); Insulin Resistance Syndrome; Metabolic Syndrome; Heart Failure; Preserved Ejection Fraction; Coronary Artery Disease; Atrial Fibrillation (AF); Non Alcholic Fatty Liver Disease; Sarcopenia; Pericardium
Interventions: Drug: Tirzepatide
Sponsors: JULIO GRANADOS MONTIEL; Instituto Nacional de Cardiologia Ignacio Chavez; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Metropolitan Autonomous University; Universidad Nacional Autonoma de Mexico
Not yet recruiting
May 12, 2026
Conditions: Hypospadias; Pudendal Nerve Block; Penile Nerve Block; Postoperative Pain
Interventions: Procedure: Ultrasound-Guided Pudendal Nerve Block; Procedure: Ultrasound-Guided Dorsal Penile Nerve Block
Sponsors: Bangladesh Medical University
Completed
May 12, 2026
Conditions: Nicotine; Mental Health; Cardiovascular (CV) Risk; Metabolic Abnormalities
Sponsors: Karolinska Institutet; Medical University of Vienna; Uppsala University Hospital; University Hospital, Umeå; Lund University Hospital; Department of clinical sciences at Danderyd hospital
Active, not recruiting
May 12, 2026
Conditions: Older Patients; Surgery; Dexmedetomidine; Esketamine; Transcranial Direct Current Stimulation; Cognitive Function; Survival
Interventions: Drug: Dex-Esk; Drug: Placebo; Device: Active tDCS; Device: Sham tDCS
Sponsors: Peking University First Hospital; Peking University Shenzhen Hospital; Second Affiliated Hospital, School of Medicine, Zhejiang University; Fujian Medical University Union Hospital; The First Affiliated Hospital of Air Force Medicial University; Zhejiang University
Not yet recruiting
May 12, 2026
Conditions: Adenocarcinoma; Prostate Cancer; Neoplasms; Carcinoma; Neoplasms, Glandular and Epithelial; Neoplasms by Histologic Type
Interventions: Biological: TriAdeno vaccine; Drug: N-803
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
May 12, 2026
Conditions: Intermittent Fasting
Interventions: Behavioral: Time-Restricted Eating (TRE); Behavioral: Time-Restricted Eating with Intermittent Energy Restriction (TRE+IER)
Sponsors: University of South Alabama
Not yet recruiting
May 12, 2026
Conditions: Coronary Artery Disease (CAD)
Sponsors: Insel Gruppe AG, University Hospital Bern
Recruiting
May 12, 2026
Conditions: Embolism Vein; Air Embolism
Sponsors: The Affiliated Hospital of Qingdao University
Completed
May 12, 2026
Conditions: Coronary Artery Disease; High Risk PCI; Percutaneous Coronary Intervention (PCI)
Interventions: Procedure: Percutaneous Coronary Intervention; Device: Mechanical Circulatory Support
Sponsors: Guofeng Gao; Shenzhen Core Medical Technology CO.,LTD.
Not yet recruiting
May 12, 2026
Conditions: Heart Failure
Interventions: Behavioral: Dual-Task IMT; Behavioral: IMT
Sponsors: Istanbul University - Cerrahpasa
Not yet recruiting
May 12, 2026
Conditions: Older Patients; Surgery; Dexmedetomidine; Esketamine; Transcranial Direct Current Stimulation; Perioperative Neurocognitive Disorders
Interventions: Drug: Dex-Esk; Drug: Placebo; Device: Active tDCS; Device: Sham tDCS
Sponsors: Peking University First Hospital; Peking University Shenzhen Hospital; The First Affiliated Hospital of Air Force Medicial University; Zhejiang University; Second Affiliated Hospital, School of Medicine, Zhejiang University; Fujian Medical University Union Hospital
Not yet recruiting
May 12, 2026
Conditions: Sleep
Sponsors: National Institute of Environmental Health Sciences (NIEHS)
Not yet recruiting
May 12, 2026
Conditions: Sickle Cell Disease, Hemolytic Anemia
Interventions: Drug: VAS-101
Sponsors: National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
May 12, 2026
Conditions: Congenital Heart Disease; Postoperative Care; Child Development; Roy Adaptation Model-based Nursing Empowerment Program
Interventions: Behavioral: RAM-based Nursing Empowerment Program; Other: Routine Care and Educational Booklet
Sponsors: Cukurova University
Not yet recruiting
May 11, 2026
Conditions: Amyloidosis Cardiac; Heart Failure; Cardiac MRI; Spectroscopic Analysis; Diagnosis; Phenotyping
Sponsors: Heinrich-Heine University, Duesseldorf
Not yet recruiting
May 11, 2026
Conditions: Tricuspid Insufficiency; Tricuspid Regurgitation (TR); Left Ventricular Cardiac Dysfunction; Left Ventricular (LV) Systolic Dysfunction; Left Ventricular Dysfunction; Left Ventricular Ejection Fraction
Sponsors: Ceric Sàrl
Not yet recruiting
May 11, 2026
Conditions: Atrial Fibrillation (AF)
Interventions: Procedure: Focal Pulsed Field Ablation of the Coronary Sinus
Sponsors: Shanghai Zhongshan Hospital
Not yet recruiting
May 11, 2026
Conditions: CABG
Interventions: Other: elliptical exercises; Other: swiss ball exercises
Sponsors: Riphah International University
Not yet recruiting
May 11, 2026
Conditions: Anemia; Iron Deficiencies; Chronic Kidney Disease
Interventions: Drug: CTX001 With and Without Iron; Drug: CTX001 With Iron; Drug: CTX001 Multiple Dose; Drug: Placebo With and Without Iron; Drug: Placebo With Iron; Drug: Placebo Multiple Dose
Sponsors: Cajal Therapeutics Inc.
Not yet recruiting
May 11, 2026
Conditions: Postoperative Cognitive Complications; Delirium; Perioperative/Postoperative Complications; Brain Injuries; Anesthesia
Sponsors: University of Texas Southwestern Medical Center
Not yet recruiting
May 11, 2026
Conditions: Fibromyalgia Syndrome
Interventions: Device: taVNS; Behavioral: Home Exercise Program
Sponsors: Istanbul Gelisim University; Bahçeşehir University
Completed
May 11, 2026
Conditions: Bronchiectasis
Interventions: Drug: CHF10196 tablets (florensocatib); Drug: Placebo
Sponsors: Chiesi Farmaceutici S.p.A.
Not yet recruiting
May 11, 2026
Conditions: Orthostatic Hypotension; Heart Rate; Blood Pressure
Interventions: Other: diaphragmatic breathing exercise; Other: educational retraining
Sponsors: Riphah International University
Recruiting
May 11, 2026
Conditions: Coronary Artery Disease (CAD); Computed Tomography Angiography; Biomarkers; AI (Artificial Intelligence); Lipoprotein(a); Atheroscleroses, Coronary; Myocardial Ischemia
Sponsors: University of Galway; Science Foundation Ireland
Recruiting
May 11, 2026
Conditions: Subarachnoid Hemorrhage, Aneurysmal; Delayed Cerebral Ischemia; Cerebral Vasospasm; Autonomic Nervous System Diseases
Interventions: Procedure: Right-Sided Cervical Sympathetic Block at C6; Device: Transcutaneous Auricular Vagal Nerve Stimulation (taVNS)
Sponsors: University of Texas Southwestern Medical Center
Not yet recruiting
May 11, 2026
Conditions: Congenital Diaphragmatic Hernia
Interventions: Device: FETO with Goldballoon Detachable Balloon (GOLDBAL2) along with the Delivery Microcatheter (BALTACCI-BDPE100)
Sponsors: Dr Erin Perrone
Not yet recruiting
May 11, 2026
Conditions: Acute Heart Failure; Volume Overload
Interventions: Drug: Intravenous furosemide continuous infusion; Drug: Intravenous furosemide bolus injections
Sponsors: University of Aarhus; Central Denmark Region
Not yet recruiting
May 11, 2026
Conditions: Pulmonary Thromboendarterectomy; Pulmonary Embolism and Thrombosis
Interventions: Diagnostic Test: Electrical Impedance Tomography (EIT).; Diagnostic Test: Pulmonary Perfusion SPECT-CT.; Procedure: Pulmonary Thromboendarterectomy.
Sponsors: University of Sao Paulo General Hospital
Recruiting
May 11, 2026
Conditions: Chronic Obstructive Pulmonary Disease
Sponsors: Assiut University
Recruiting
May 11, 2026
Conditions: Mortality; Clinical Deterioration; Geriatric Patients; Frailty; Emergency Department Visits
Interventions: Other: Demographic Characteristics; Other: Comorbidities; Other: Vital Signs; Other: Laboratory Parameters; Other: Severity Scores; Other: Clinical Frailty Scale; Other: Early Warning Scores
Sponsors: Haseki Training and Research Hospital
Completed
May 11, 2026
Conditions: Healthy Adults
Interventions: Dietary Supplement: Three-Strain Probiotic; Dietary Supplement: Phase 2 - Placebo
Sponsors: Pendulum Therapeutics; Atlantia Food Clinical Trials; APC Microbiome Ireland
Active, not recruiting
May 11, 2026
Conditions: Abdominal Aneurysm; Aortic Aneurysm; Aortic Aneurysm Abdominal
Sponsors: Karolinska University Hospital; Karolinska Institutet; Swedish Heart Lung Foundation
Active, not recruiting
May 11, 2026
Conditions: Cardiogenic Shock
Interventions: Device: SynFlow Duro
Sponsors: ForQaly Medical (Shanghai) Co., Ltd
Not yet recruiting
May 11, 2026
Conditions: Coronary Artery Disease
Interventions: Procedure: Initial Invasive Strategy; Drug: Initial Conservative Strategy
Sponsors: Seung-Jung Park; CardioVascular Research Foundation, Korea
Not yet recruiting
May 11, 2026
Conditions: Cutaneous Tumors; Mohs Micrographic Surgery
Interventions: Drug: Norco 5Mg-325Mg Tablet; Drug: Suzetrigine
Sponsors: Baylor Research Institute
Enrolling by invitation
May 11, 2026
Conditions: Blood Cholesterol; Blood Pressure Monitoring; Weight Change; BMI; Diabetes Education; Diabetes (DM)
Interventions: Behavioral: Remote Patient Monitoring in a Faith-Based Program; Behavioral: Traditional Cohort Faith-based DSMES program
Sponsors: University of Alabama at Birmingham; National Institute on Minority Health and Health Disparities (NIMHD)
Not yet recruiting
May 11, 2026
Conditions: Chronic Coronary Syndrome
Interventions: Drug: Aspirin; Drug: Clopidgrel 75 mg daily
Sponsors: Khalid F Alhabib
Not yet recruiting
May 08, 2026
Conditions: Vestibular Disorder
Interventions: Other: Group A Habituation exercises; Other: Group B Optokinetic training protocol
Sponsors: Riphah International University
Not yet recruiting
May 08, 2026
Conditions: Cardiomyopathy; Atrial Fibrillation (AF); Genetic
Sponsors: Barts & The London NHS Trust
Recruiting
May 08, 2026
Conditions: Heart Failure; NYHA Class III Heart Failure; NYHA Class II Heart Failure
Interventions: Device: IVC Sensor
Sponsors: Foundry Innovation & Research 1, Limited (FIRE1); NAMSA; Baim Institute for Clinical Research
Not yet recruiting
May 08, 2026
Conditions: Myocardial Infarction First
Interventions: Other: Plant based diet; Other: Diet based on the recommendations of the European Society of Cardiology
Sponsors: Radana Dymáčková; Masaryk University
Completed
May 08, 2026
Conditions: Perioperative Care
Sponsors: Karolinska Institutet
Completed
May 08, 2026
Conditions: Intellectual Disabilities
Interventions: Behavioral: Traditional physical conditioning; Behavioral: Sport-based individual skills
Sponsors: Universidad Católica San Antonio de Murcia
Enrolling by invitation
May 08, 2026
Conditions: Atrial Fibrillation; Stroke Prevention in Patients With Atrial Fibrillation; Left Atrial Appendage Closure; Hemorrhage; Anticoagulants / Administration & Dosage; Reduced-dose Apixaban; Thromboembolism
Interventions: Device: Left Atrial Appendage Closure; Drug: Apixaban 2.5 mg BID; Drug: Standard-dose DOAC
Sponsors: National Medical Research Center for Therapy and Preventive Medicine
Recruiting
May 08, 2026
Conditions: Congenital Diaphragmatic Hernia
Interventions: Device: Fetoscopic Endoluminal Tracheal Occlusion; Other: Standard of Care
Sponsors: Mayo Clinic
Not yet recruiting
May 08, 2026
Conditions: Coronary Artery Disease; Myocardial Revascularization; Postoperative Recovery After Cardiac Surgery; Nursing Care
Interventions: Behavioral: Nursing Intervention Program; Other: Usual Care
Sponsors: Universidad de la Sabana
Not yet recruiting
May 08, 2026
Conditions: Developmental Delay (Disorder)
Interventions: Behavioral: Mindful movement; Behavioral: Game based training
Sponsors: Riphah International University
Not yet recruiting
May 08, 2026
Conditions: HFpEF - Heart Failure With Preserved Ejection Fraction; TAVI(Transcatheter Aortic Valve Implantation); Finerenone
Interventions: Drug: Finerenone; Drug: Placebo
Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting
May 08, 2026
Conditions: Obsessive - Compulsive Disorder; Transcranial Magnetic Stimilation; Intermittent Theta Burst Stimulation; EEG
Interventions: Device: iTBS TMS
Sponsors: Istanbul University - Cerrahpasa
Recruiting
May 08, 2026
Conditions: Congenital Heart Disease; Arrhythmia; Ablation of Arrhythmias
Sponsors: Fayoum University
Completed
May 08, 2026
Conditions: Morbid Obesity Requiring Bariatric Surgery
Sponsors: University Hospital, Geneva
Recruiting
May 08, 2026
Conditions: Fabry Disease
Interventions: Other: Qualitative Interview
Sponsors: Vastra Gotaland Region; Karolinska University Hospital; Sahlgrenska University Hospital
Not yet recruiting
May 08, 2026
Conditions: Depressive Disorder, Major
Interventions: Drug: Seltorexant; Drug: Placebo
Sponsors: Janssen Research & Development, LLC
Recruiting
May 08, 2026
Conditions: Heart Failure
Interventions: Drug: GDMT; Other: Quality of life questionnaire
Sponsors: Università Vita-Salute San Raffaele
Not yet recruiting
May 08, 2026
Conditions: Calcific Aortic Valve Disease; Inflammation; Dysbiosis; TAVI
Sponsors: Insel Gruppe AG, University Hospital Bern; Tours university
Active, not recruiting
May 08, 2026
Conditions: Congenital Heart Disease (CHD); Congenital Heart Disease in Children
Interventions: Behavioral: JITAI-Based Digital Exercise Rehabilitation Program; Behavioral: Standard Exercise Rehabilitation Program
Sponsors: The Children's Hospital of Zhejiang University School of Medicine; Children's Hospital of Nanjing Medical University; Beijing Children's Hospital
Not yet recruiting
May 08, 2026
Conditions: Congenital Heart Disease (CHD); Chest Tube Removal
Interventions: Behavioral: Music Group; Behavioral: Musical Mobile Group
Sponsors: Baskent University
Not yet recruiting
May 08, 2026
Conditions: COPD; Pulmonary Hypertension; Exercise; Right Ventricular (RV) Dysfunction; Exercise Training
Interventions: Behavioral: Exercise training
Sponsors: University of Colorado, Denver; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
May 08, 2026
Conditions: Heart Failure
Interventions: Drug: potassium binder
Sponsors: Sahlgrenska University Hospital
Not yet recruiting
May 08, 2026
Conditions: Hypertension; Hypercholesterolemia
Interventions: Drug: Amlodipine; Drug: Ezetimibe/Rosuvastatin; Drug: Ezetimibe/Rosuvastatin Placebo; Drug: Amlodipine Placebo
Sponsors: Celltrion Pharm, Inc.
Completed
May 08, 2026
Conditions: Airway Management; Tracheal Intubation; Emergency Department; Peri-intubation Adverse Events
Sponsors: Chang Gung Memorial Hospital
Not yet recruiting
May 08, 2026
Conditions: Paroxysmal Atrial Fibrillation (PAF); Persistent Atrial Fibrillation
Interventions: Device: PulseSelect Pulse Field Ablation (PFA) System
Sponsors: Medtronic Cardiac Ablation Solutions
Not yet recruiting
May 07, 2026
Conditions: Paroxysmal Atrial Fibrillation (PAF); Atrial Flutter
Sponsors: National Taiwan University Hospital; Biotronik SE & Co. KG
Not yet recruiting
May 07, 2026
Conditions: Frailty Syndrome; Older Adults; Blood Flow Restriction (BFR) Training Effects; Inspiratory Muscle Training
Interventions: Behavioral: Exercise; Behavioral: Sham Control
Sponsors: Taipei Medical University; National Taiwan University; The University of Texas at Austin
Not yet recruiting
May 07, 2026
Conditions: Ventricular Tachycardia (VT)
Interventions: Procedure: Dynamic Voltage Mapping; Procedure: Standard of Care Ablation
Sponsors: Liverpool Heart and Chest Hospital NHS Foundation Trust
Not yet recruiting
May 07, 2026
Conditions: Community-dwelling Elderly
Interventions: Other: tDCS; Other: Sham stimulation
Sponsors: Riphah International University
Not yet recruiting
May 07, 2026
Conditions: Heart Failure Due to Coronary Artery Disease; Valvular Cardiomyopathy; Heart Failure
Interventions: Drug: Sacubitril / Valsartan; Drug: SGLT-2 inhibitor; Drug: Sacubitril / Valsartan; Drug: SGLT2 Inhibition
Sponsors: Kyungsub Song; Seoul National University Bundang Hospital; Korea University Anam Hospital; Ajou University Medical Center
Not yet recruiting
May 07, 2026
Conditions: Type 2 Diabetes
Interventions: Behavioral: Cold exposure with shivering
Sponsors: Université de Sherbrooke; Maastricht University Medical Center
Recruiting
May 07, 2026
Conditions: Cardiac Arrest (CA); Out-of-hospital Cardiac Arrest (OHCA); Asystole; Pulseless Electrical Activity; Ventricular Fibrillation
Interventions: Device: Abdominal Aortic Junction Tourniquet in non-traumatic out-of-hospital cardiac arrest
Sponsors: Klinikum Klagenfurt am Wörthersee
Not yet recruiting
May 07, 2026
Conditions: Type 2 Diabetes Mellitus (T2DM); Beta Cell Function
Interventions: Other: Monitor and observe the clinical progression and beta cell function
Sponsors: University Medical Center Ho Chi Minh City (UMC)
Recruiting
May 07, 2026
Conditions: Interstitial Lung Disease; Pulmonary Fibrosis
Interventions: Drug: [68Ga]CBP8; Drug: Gadoterate Meglumine
Sponsors: Peter Caravan; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
May 07, 2026
Conditions: Migraine; Sleep Disorder (Disorder); Stress; Migraine in Adults
Interventions: Behavioral: Profile-based behavioral sleep and stress management
Sponsors: Susanne Wegener
Recruiting
May 07, 2026
Conditions: Type 1 Diabetes; Overweight
Interventions: Other: Exercise training
Sponsors: University of Virginia
Recruiting
May 07, 2026
Conditions: Valvular Heart Diseases; Valvular Heart Disease Stenosis and Regurgitation; Regurgitation, Aortic Valve; Regurgitation, Mitral
Sponsors: Shanghai Zhongshan Hospital
Completed
May 07, 2026
Conditions: Complex Congenital Heart Disease
Interventions: Behavioral: Community-Based Remote Cardiac Rehabilitation Program; Behavioral: standard of care
Sponsors: Seoul National University Hospital; University of Seoul
Recruiting
May 07, 2026
Conditions: Neonatal Sepsis, Markers
Interventions: Diagnostic Test: cardiac troponin, and blood culture
Sponsors: Assiut University
Not yet recruiting
May 07, 2026
Conditions: Cardiovascular Risk Factor
Interventions: Behavioral: Multicomponent Virtual Lifestyle Intervention
Sponsors: Truemedicine Inc
Enrolling by invitation
May 07, 2026
Conditions: Atopic Dermatitis
Interventions: Dietary Supplement: vit k2; Other: Placebo
Sponsors: October 6 University
Completed
May 07, 2026
Conditions: Percutaneous Coronary Intervention (PCI); Radial Artery Occlusion; Radial Artery Spasm
Interventions: Procedure: catheterization of the radial artery using an classic introducer; Procedure: catheterization of the radial artery using an introducer with a standard outer diameter and an outer hydrophilic coating; Procedure: catheterization of the radial artery using an introducer with a reduced outer diameter and an outer hydrophilic coating
Sponsors: Pirogov Russian National Research Medical University; I.M. Sechenov First Moscow State Medical University
Completed
May 07, 2026
Conditions: Atrial Fibrillation
Interventions: Device: CARTO SOUND™ FAM System with Varipulse™ PFA Catheter
Sponsors: China National Center for Cardiovascular Diseases; Central China Fuwai Hospital of Zhengzhou University; The Affiliated Hospital of Qingdao University
Not yet recruiting
May 07, 2026
Conditions: Healthy Adults
Sponsors: Riphah International University
Enrolling by invitation
May 07, 2026
Conditions: Cardiac Arrhythmia; Anesthesia
Interventions: Procedure: low flow anesthesia
Sponsors: Istanbul University
Not yet recruiting
May 07, 2026
Conditions: Stage 1 Hypertensives
Interventions: Other: Coherent Breathing.; Other: Aerobic Exercises
Sponsors: Foundation University Islamabad
Recruiting
May 07, 2026
Conditions: CABG
Interventions: Device: IMT Threshold device
Sponsors: Riphah International University
Not yet recruiting
May 07, 2026
Conditions: Post-menopause
Interventions: Dietary Supplement: Beetroot Juice (Beet-It Stamina Shot) & Supervised Exercise Training
Sponsors: Western Norway University of Applied Sciences
Recruiting
May 07, 2026
Conditions: Burn Injury
Interventions: Device: Non-Invasive Vagus Nerve Stimulation; Other: Conventional Physiotherapy
Sponsors: Fenerbahce University
Enrolling by invitation
May 07, 2026
Conditions: Anthracycline-induced Cardiotoxicity; Lymphoma; Chemotherapy; Cardiotoxicity
Interventions: Drug: Sotagliflozin; Drug: Placebo
Sponsors: Icahn School of Medicine at Mount Sinai; American Heart Association
Not yet recruiting
May 07, 2026
Conditions: Acute Hypoxic Respiratory Failure; Acute Respiratory Distress Syndrome (ARDS)
Interventions: Device: Non-Invasive Positive Pressure Ventilation; Device: High Flow Nasal Oxygen
Sponsors: Ohio State University; National Heart, Lung, and Blood Institute (NHLBI); University of Michigan; Medical University of South Carolina; University of Arizona; Baystate Medical Center
Not yet recruiting
May 07, 2026
Conditions: Atrial Fibrillation (AF); Atrial Fibrillation
Interventions: Procedure: Conventional Electrical Cardioversion; Procedure: Dual-shock Electrical Cardioversion
Sponsors: Martín Negreira Caamaño
Not yet recruiting
May 07, 2026
Conditions: Atrial Fibrillation; Biomarker
Sponsors: National Taiwan University Hospital
Withdrawn
May 07, 2026
Conditions: Intracranial Atherosclerotic Disease (ICAD); Hypertriglyceridaemia; Stroke (CVA) or TIA
Interventions: Drug: Pemafibrate
Sponsors: Tokyo Women's Medical University; Kowa Company, Ltd.
Not yet recruiting
May 07, 2026
Conditions: Heart Failure; Prefrail Elderly; Frail Elderly Syndrome
Interventions: Behavioral: Telerehabilitation; Behavioral: Caregiver-Supervised Home Exercise Program
Sponsors: University of Salerno; Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona
Not yet recruiting
May 07, 2026
Conditions: Burn Injury
Interventions: Device: Non-Invasive Vagus Nerve Stimulation; Other: Conventional Physiotherapy
Sponsors: Fenerbahce University
Enrolling by invitation
May 07, 2026
Conditions: Esophageal Cancer; Gastric Cancer (Diagnosis); Upper Gastrointestinal Cancer
Interventions: Behavioral: High-Intensity Interval Training (HIIT); Behavioral: Low-Intensity Continuous Training (LICT)
Sponsors: Kansai Medical University
Not yet recruiting
May 07, 2026
Conditions: Menstrual Dysfunction
Interventions: Other: Heat stress; Other: Sleep stress; Other: Exercise stress
Sponsors: Duke University
Not yet recruiting
May 06, 2026
Conditions: Atrial Fibrillation (AF)
Interventions: Drug: Anticoagulant Therapy; Drug: Probiotics capsules
Sponsors: Ain Shams University
Not yet recruiting
May 06, 2026
Conditions: Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes
Interventions: Drug: Testosterone Enanthate; Drug: Testosterone Cypionate; Drug: Testosterone Propionate; Drug: Sustanon (testosterone); Drug: Testosterone Gel; Drug: Methenolone Enanthate (Primobolan); Drug: Nandrolone Decanoate (Deca-Durabolin); Drug: Estradiol Patch; Drug: Estradiol Capsule; Drug: Progesterone Cream; Drug: Progesterone Capsule; Drug: Human Growth Hormone (hGH); Drug: EPO Darbepoetin (Aranesp); Drug: Meldonium; Drug: Modafinil; Drug: Mixed amphetamine salts (Adderall); Drug: Clomiphene; Drug: Anastrozole; Drug: Levothyroxine; Drug: Liothyronine; Drug: hCG; Drug: hMG; Drug: Atorvastatin; Drug: Rosuvastatin; Drug: Bisoprolol; Drug: Nebivolol; Drug: Metoprolol; Drug: Propranolol; Drug: Lisinopril; Drug: Enalapril; Drug: Furosemide; Drug: Chlorothiazide; Drug: Cabergoline; Drug: Metformin; Drug: Basal Insulin Glargine (long-acting); Drug: Telmisartan; Drug: Losartan
Sponsors: Enhanced Emirates Limited
Enrolling by invitation
May 06, 2026
Conditions: Coronary Artery Disease; Atrial Fibrillation
Interventions: Drug: Liposomal bupivacaine; Drug: Placebo
Sponsors: Mayo Clinic
Not yet recruiting
May 06, 2026
Conditions: CMT - Charcot-Marie-Tooth Disease; CMT1A; CMT (Charcot Marie Tooth Disease)
Sponsors: University Medical Center Goettingen
Recruiting
May 06, 2026
Conditions: Ventricular Arrhythmias and Cardiac Arrest
Interventions: Drug: Mirabegron
Sponsors: Cedars-Sinai Medical Center
Not yet recruiting
May 06, 2026
Conditions: Mantle Cell Lymphoma (MCL)
Interventions: Biological: zamtocabtagene autoleucel (MB-CART2019.1); Drug: Cyclophosphamide; Drug: Fludarabine
Sponsors: Miltenyi Biomedicine GmbH; National Heart, Lung, and Blood Institute (NHLBI); National Cancer Institute (NCI)
Not yet recruiting
May 06, 2026
Conditions: Heart Failure With Reduced Ejection Fraction
Interventions: Other: Comparator Arm; Drug: HFrEF Polypill
Sponsors: Washington University School of Medicine; The George Institute; Centre for Chronic Disease Control, India; National Heart, Lung, and Blood Institute (NHLBI); RemediumOne
Not yet recruiting
May 06, 2026
Conditions: Stroke
Interventions: Other: Physical activity maintenance
Sponsors: University of Ulster; Northern Ireland Chest Heart and Stroke
Active, not recruiting
May 06, 2026
Conditions: Aphasia
Interventions: Device: LEXURE; Behavioral: Workbook
Sponsors: Nunaps Inc
Recruiting
May 06, 2026
Conditions: Ischemic Heart Disease (IHD); Anxiety; Depression
Interventions: Other: Online psychological therapy
Sponsors: University of Southern Denmark; Aarhus University Hospital Skejby; Aalborg University Hospital; Zealand University Hospital
Recruiting
May 06, 2026
Conditions: Heart Valve Diseases
Interventions: Device: BPM Core
Sponsors: The University of Hong Kong
Recruiting
May 06, 2026
Conditions: Dental Anxiety in Children
Interventions: Behavioral: Visual Educational Leaflet
Sponsors: Istanbul University
Completed
May 06, 2026
Conditions: Depression in Adolescence; Obesity & Overweight; Cognitive-behavioral Therapy; Mobile Health Technology (mHealth); Health Behavior
Interventions: Behavioral: Cognitive-behavioral therapy (CBT); Behavioral: Digital app
Sponsors: Colorado State University; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
May 06, 2026
Conditions: Peripheral Occlusive Disease; Wound Healing; Wound Healing Complication; Cold Atmospheric Plasma; Prevention
Interventions: Device: Cold atmospheric plasma; Device: Sham device
Sponsors: Ursula Werra; neoplas med GmbH; Universitätsklinikum Hamburg-Eppendorf
Not yet recruiting
May 06, 2026
Conditions: Major Depressive Disorder (MDD); Anxiety Disorder; Alcohol Use Disorder (AUD)
Interventions: Device: wearable monitoring devices
Sponsors: Huashan Hospital
Not yet recruiting
May 06, 2026
Conditions: Walking; Older Adults (65 Years and Older); Messaging; Mobile Applications; Reminder Systems; Psychosocial Factors; Psychosocial Effects and Treatment; Physical Activity Promotion; Health Behaviour; Functional Decline; Aging Problems
Interventions: Behavioral: Nostalgia-based messages promoting walking; Behavioral: Step-monitoring reminders promoting walking; Behavioral: Messages about water intake benefits; Behavioral: Nostalgia-based messages & Step-monitoring reminders promoting walking
Sponsors: Catholic University, Italy; IPSOS
Not yet recruiting
May 06, 2026
Conditions: Antiphospholipid Syndrome; Vitamine K Antagonist (VKA) Treatment
Interventions: Device: Coaguchek
Sponsors: Central Hospital, Nancy, France
Not yet recruiting
May 06, 2026
Conditions: Chronic Cough
Interventions: Behavioral: Acceptance and Commitment Therapy (ACT)
Sponsors: University of North Carolina, Chapel Hill; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
May 06, 2026
Conditions: Atrial Fibrillation; Electric Countershock; Deep Sedation
Interventions: Drug: BIS-guided propofol sedation; Drug: Clinical-guided propofol sedation
Sponsors: Istanbul University - Cerrahpasa
Not yet recruiting
May 06, 2026
Conditions: Septic Shock, Vasopressor Resistance
Interventions: Drug: Dexmedetomidine 100 µg/mL, intravenous solution; Other: Stardard care
Sponsors: Hospices Civils de Lyon; Centre Hospitalier Universitaire Dijon
Not yet recruiting
May 06, 2026
Conditions: Atrial Fibrillation (AF); Atrial Flutter
Interventions: Other: One-step cardiologist-only midazolam sedation; Other: Two-step anaesthesiologist-assisted propofol sedation
Sponsors: Gødstrup Hospital; University of Aarhus
Not yet recruiting
May 06, 2026
Conditions: CAD - Coronary Artery Disease; CABG; Colchicine
Interventions: Drug: Colchicine Pill; Drug: Placebo
Sponsors: Beijing Anzhen Hospital
Not yet recruiting
May 06, 2026
Conditions: Coronary Artery Disease (CAD); Calcific Coronary Arteriosclerosis; Intravascular Lithotripsy; Rotational Atherectomy; OFDI; Orbital Atherectomy; Optical Coherence Tomography (OCT); Intravascular Ultrasound; Percutaneous Coronary Intervention
Interventions: Procedure: Percutaneous coronary intervention with or without stent implantation
Sponsors: Papa Giovanni XXIII Hospital
Not yet recruiting
May 05, 2026
Conditions: Severe Aortic Valve Stenosis; Valvular Heart Disease; Aortic Valve Stenosis
Interventions: Device: Hydra THV
Sponsors: Fundación EPIC
Not yet recruiting
May 05, 2026
Conditions: Ischemic Stroke
Interventions: Device: Measuring Absolute Cerebral Flow and Microvascular Resistance by Thermodilution
Sponsors: Centre Hospitalier Universitaire de Nice
Recruiting
May 05, 2026
Conditions: Gestational Diabetes Mellitus (GDM); Type 2 Diabetes (T2DM); High-intensity Interval Training
Interventions: Other: High-intensity interval training
Sponsors: Odense University Hospital; University of Southern Denmark
Enrolling by invitation
May 05, 2026
Conditions: Aortic Coarctation; Cardiac Output, Low
Interventions: Device: MostCare (PRAM); Device: Near-Infrared Spectroscopy (NIRS); Procedure: Arterial Blood Gas with Lactate
Sponsors: Konya City Hospital
Not yet recruiting
May 05, 2026
Conditions: Acute Myocardial Infarction (AMI); ST-Segment Elevation Myocardial Infarction(STEMI); Non-ST-Segment Elevation Myocardial Infarction(NSTEMI)
Interventions: Drug: Guideline-recommended standard medical therapy alone; Procedure: DES implantation plus guideline-recommended standard medical therapy
Sponsors: Harbin Medical University
Not yet recruiting
May 05, 2026
Conditions: Assessment of Some Hormone Levels in Children With Dilated Cardiomyopathy
Interventions: Diagnostic Test: Echocardiography assessment.; Diagnostic Test: Laboratory investigations and Hormone assessment.
Sponsors: Sohag University
Not yet recruiting
May 05, 2026
Conditions: Obesity; Heart Failure
Interventions: Drug: NNC0487-0111; Drug: Placebo
Sponsors: Novo Nordisk A/S
Not yet recruiting
May 05, 2026
Conditions: Atrial Fibrillation (AF); Cardiac Amyloidosis
Interventions: Diagnostic Test: AI-ECG analysis; Diagnostic Test: CT-ECV analysis; Other: Atrial fibrillation treatment
Sponsors: Samsung Medical Center; Mayo Clinic
Not yet recruiting
May 05, 2026
Conditions: Patent Ductus Arterioses
Interventions: Procedure: Transcatheter Patent Ductus Arteriosus Closure
Sponsors: Emil Magdy Badry
Not yet recruiting
May 05, 2026
Conditions: Burns
Interventions: Device: Efferon LPS
Sponsors: Efferon JSC
Not yet recruiting
May 05, 2026
Conditions: Neurodegenerative Disease; Artificial Intelligence (AI); Mild Cognitive Impairment (MCI)
Interventions: Device: CLINICAL INVESTIGATION WITH A MEDICAL DEVICE MARKED CE
Sponsors: IRCCS Centro Neurolesi Bonino Pulejo
Completed
May 05, 2026
Conditions: Septic Shock; Cirrhosis; Vasodilatory Shock; Acute Kidney Injury
Interventions: Drug: Giapreza
Sponsors: The Cleveland Clinic; Innoviva Specialty Therapeutics
Active, not recruiting
May 05, 2026
Conditions: Angina, Microvascular
Interventions: Procedure: Investigation of Systemic Endothelial Microvascular Function
Sponsors: National Institute of Cardiology, Laranjeiras, Brazil
Not yet recruiting
May 05, 2026
Conditions: Patient Compliance; Mobile Applications; Reminder Systems
Interventions: Behavioral: Loss-Framed Reminder; Behavioral: Logging Consistency Reminder; Behavioral: Neutral Reminder
Sponsors: University of St.Gallen
Recruiting
May 05, 2026
Conditions: Obstructive Apnea; Diagnostic; Sleep Apnea Syndrome (OSAS)
Sponsors: Insel Gruppe AG, University Hospital Bern
Not yet recruiting
May 05, 2026
Conditions: Congenital Heart Disease
Interventions: Other: Accessible Care Model Visit; Other: Recruitment Interviews; Other: Participating Patient-Support Person Interviews; Other: Participating Patient-Support Person Surveys; Other: Participating Provider Interviews and surveys; Other: Unstructured and semi-structured interviews
Sponsors: University of Wisconsin, Madison
Recruiting
May 04, 2026
Conditions: Rhinitis Allergic
Interventions: Biological: Recombinant Artemisia vulgaris allergen Art v 1 with Montanide ISA-51 adjuvant; Biological: Montanide ISA-51 placebo emulsion
Sponsors: Kazakh National Agrarian University
Not yet recruiting
May 04, 2026
Conditions: Rupture of Membranes Prior to Onset of Labor
Interventions: Drug: Ampicillin; Drug: Ampicillin + gentamicin
Sponsors: Sarawak General Hospital
Not yet recruiting
May 04, 2026
Conditions: Platinum-Sensitive Ovarian Cancer; Ovarian Cancer
Interventions: Biological: Rina-S; Drug: Bevacizumab; Drug: Carboplatin; Drug: Gemcitabine; Drug: Paclitaxel; Drug: PLD
Sponsors: Genmab
Not yet recruiting
May 04, 2026
Conditions: Dialysis; Complications
Interventions: Device: A - Dialysate magnesium 0.75; Device: B - Dialysate magnesium 1.00 mmol/L
Sponsors: Universitaire Ziekenhuizen KU Leuven; Fresenius AG
Completed
May 04, 2026
Conditions: Aging; Aging Well; All-Cause Mortality; Mortality; Metabolic Syndrome; Cardiovascular Diseases; Cognitive Dysfunction; Musculoskeletal Diseases; Neoplasms; Frailty; Activities of Daily Living; Health-Related Quality of Life; Disability Physical; Neuro-Degenerative Disease; Dementia
Interventions: Diagnostic Test: Comprehensive Multi-System Clinical Screening
Sponsors: Longevity Metrics, Inc.
Recruiting
May 04, 2026
Conditions: Arrhythmogenic Right Ventricular Cardiomyopathy; FAPI PET; Cardiac Magnetic Resonance Imaging
Interventions: Diagnostic Test: 68Ga-DOTA-SA-FAPI PET/CT
Sponsors: Istanbul University - Cerrahpasa
Recruiting
May 04, 2026
Conditions: HER-2 Positive Breast Cancer
Interventions: Drug: Lipo-Dox®; Drug: Cyclophosphamide; Drug: Trastuzumab (Herceptin); Drug: Pertuzumab
Sponsors: National Taiwan University Hospital; TTY Biopharm
Not yet recruiting
May 04, 2026
Conditions: Phantom Limb Pain; Neuropathic Pain; Lower Limb Amputation
Interventions: Drug: Hyperbaric Bupivacaine plus Saline; Drug: Hyperbaric Bupivacaine plus Dexmedetomidine
Sponsors: Universidad Juárez Autónoma de Tabasco
Completed
May 04, 2026
Conditions: Pulmonary Hypertension
Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia
Recruiting
May 04, 2026
Conditions: Safety Study
Interventions: Other: Hyperthermia
Sponsors: Marc Abreu
Enrolling by invitation
May 04, 2026
Conditions: Obesity; Type 2 Diabetes
Interventions: Drug: Cagrisema; Drug: Semaglutide
Sponsors: Novo Nordisk A/S
Not yet recruiting
May 04, 2026
Conditions: ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Interventions: Drug: JMKX003142 tablets; Drug: Fluconazole Capsules; Drug: Cocktail Substrates (Midazolam Oral Solution, Rosuvastatin Calcium Tablets, and Digoxin Tablets); Drug: Cyclosporine Soft Capsules; Drug: Omeprazole Enteric-coated Tablets; Drug: Efavirenz Tablets; Drug: JMKX003142 tablets; Drug: JMKX003142 tablets; Drug: JMKX003142 tablets
Sponsors: Jemincare; Zhejiang Hangyu Pharmaceutical Co., Ltd.
Not yet recruiting
May 04, 2026
Conditions: Atrial Fibrillation (AF); Cardiac Arrhythmias
Interventions: Device: Smartcardia 7L Patch; Device: ECG247; Device: HeartX Recorder; Device: Kardiobeat; Device: net_ECG; Device: ZIO Patch
Sponsors: Medical University Innsbruck
Active, not recruiting
May 04, 2026
Conditions: Geriatric Patients; Postoperative Complications; Frailty; Myocardial Ischemia; Hip Surgeries
Interventions: Other: Preoperative Risk Assessment and Machine Learning Modeling
Sponsors: DİLEK KALAYCI
Active, not recruiting
May 04, 2026
Conditions: Myocardial Infarction (MI); Acute Coronary Syndromes (ACS)
Interventions: Diagnostic Test: Prehospital high-sensitivity cardiac troponin I measurement
Sponsors: Central Denmark Region
Not yet recruiting
May 04, 2026
Conditions: GERD (Heartburn, Regurgitation, and Dyspepsia); Gastroesophageal Reflux (GERD)
Interventions: Device: Syrup made by hyaluronic acid
Sponsors: Rose Pharma SA
Completed
May 04, 2026
Conditions: Obesity; Diastolic Dysfunction; Heart Failure With Preserved Ejection Fraction (HFPEF)
Sponsors: Itshak Amsalem
Not yet recruiting
May 04, 2026
Conditions: Sarcopenia; Fatigue; Orthostatic Intolerance
Sponsors: Ain Shams University
Not yet recruiting
May 04, 2026
Conditions: Cerebral Palsy (CP)
Interventions: Behavioral: Extended Reality Exergaming
Sponsors: University of Alabama at Birmingham
Not yet recruiting
May 04, 2026
Conditions: Erectile Dysfunction; Left Ventricular Diastolic Dysfunction; Metabolic Syndrome
Interventions: Drug: Tadalafil 5 mg; Drug: SGLT-2 inhibitor; Drug: Tadalafil plus SGLT2 inhibitors
Sponsors: Kafrelsheikh University
Completed
May 04, 2026
Conditions: Atherosclerotic Renal Artery Stenosis; Hypertension; Renal Artery Stenosis
Interventions: Device: Covered Stent; Device: Bare Metal Stent
Sponsors: Chinese Academy of Medical Sciences, Fuwai Hospital
Not yet recruiting
May 04, 2026
Conditions: Labor Pain; Anxiety; Stress, Psychological
Interventions: Behavioral: Guided Breathing Exercises During Labor
Sponsors: Nilgun Avci
Completed
May 04, 2026
Conditions: Metastatic Melanoma
Interventions: Behavioral: 30 Minutes Cycle Ergometer
Sponsors: Universitätsklinikum Hamburg-Eppendorf
Recruiting
May 04, 2026
Conditions: Out of Hospital Cardiac Arrest; Pain
Sponsors: Region Skane
Recruiting
May 04, 2026
Conditions: Pulmonary Hypertension
Interventions: Dietary Supplement: Nicotinamide Riboside (NR); Drug: Placebo
Sponsors: Vanderbilt University Medical Center; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
May 04, 2026
Conditions: Coronary Artery Disease
Interventions: Device: Sirolimus-Ascorbic Acid Eluting Stent; Device: Everolimus-Eluting Stent
Sponsors: Jung-min Ahn; The CardioVascular Research Foundation (CVRF)
Not yet recruiting
May 04, 2026
Conditions: Heart Failure, Diastolic; Heart Failure With Preserved Ejection Fraction; Obesity
Interventions: Drug: Tirzepatide
Sponsors: Columbia University
Not yet recruiting
May 04, 2026
Conditions: Cardiovascular Surgical Procedures; Pain, Postoperative; Cardiovascular Diseases
Interventions: Procedure: Ultrasound-Guided Pectointercostal Fascial Plane Block; Procedure: Ultrasound-Guided Rectus Sheath Block; Procedure: Ultrasound-Guided Recto-Intercostal Fascial Plane Block
Sponsors: Ordu University
Recruiting
May 01, 2026
Conditions: Coronary Artery Disease; Acute Coronary Syndrome; Myocardial Infarction; Stent Thrombosis; Percutaneous Coronary Intervention
Interventions: Device: ABLUMINUS NP polymer-free sirolimus-eluting stent
Sponsors: Dorian Garin
Not yet recruiting
May 01, 2026
Conditions: Chronic Heart Failure; Type 2 Diabetes; Diabetes (DM)
Interventions: Other: Diabetes Status; Other: Comorbidity Burden; Other: Weight variability
Sponsors: Satelia
Completed
May 01, 2026
Conditions: MDD; Major Depressive Disorder (MDD); Major Depression; Suicidal Ideation; Suicide
Interventions: Drug: N,N-Dimethyltryptamine (15 mg + 60 mg); Drug: N,N-Dimethyltryptamine (1 mg + 4 mg)
Sponsors: Universidade Federal do Rio Grande do Norte; Financiadora de Estudos e Projetos
Not yet recruiting
May 01, 2026
Conditions: Heart Failure
Interventions: Other: Normal Salt Diet; Other: Cardiac Diet
Sponsors: Maya Guglin, MD
Recruiting
May 01, 2026
Conditions: Delirium Risk; Critical Illness in Coronary ICU Patients; Mental and Spiritual Recovery; Effects of Virtual Art Therapy
Interventions: Other: Virtual Art Therapy
Sponsors: Inonu University
Not yet recruiting
May 01, 2026
Conditions: Pulmonary Hypertension; Interstitial Lung Disease
Interventions: Behavioral: Home Exercise Program, Aerobic Plus Strength Training; Behavioral: Home Exercise Program, Aerobic Only
Sponsors: University of Rochester; Liquidia Technologies, Inc.
Not yet recruiting
May 01, 2026
Conditions: Heart Failure; Bradycardia
Interventions: Procedure: Adjustment of the pacemaker/ICDs lower rate limit (LRL); Procedure: Conventional lower rate (60bpm)
Sponsors: Samsung Medical Center
Recruiting
May 01, 2026
Conditions: Recurrent Pregnancy Loss; Overweight , Obesity; Heart-Brain Coupling
Interventions: Device: Real repetitive transcranial magnetic stimulation; Device: Sham repetitive transcranial magnetic stimulation
Sponsors: Shenyang Medical College
Not yet recruiting
May 01, 2026
Conditions: Cardiac Magnetic Resonance
Interventions: Diagnostic Test: CMR scan
Sponsors: Istituto Auxologico Italiano
Completed
May 01, 2026
Conditions: Intrahepatic Cholestasis of Pregnancy
Interventions: Drug: Normal Saline (0.9% NaCl); Drug: Esketamine 0.3mg/kg
Sponsors: Tianjin Medical University General Hospital
Not yet recruiting
May 01, 2026
Conditions: Food Insecurity
Interventions: Behavioral: Upscaling the Wabanaki Mobile Food Pantry Program
Sponsors: Wabanaki Public Health and Wellness; Yale University; Washington State University
Not yet recruiting
May 01, 2026
Conditions: Heart Failure With Preserved Ejection Fraction (HFPEF); Coronary Artery Disease
Interventions: Procedure: Percutaneous coronary intervention; Other: Placebo procedure
Sponsors: King's College London; Guy's and St Thomas' NHS Foundation Trust
Recruiting
May 01, 2026
Conditions: Cardiogenic Shock
Interventions: Drug: Norepinephrine; Drug: Dopamine Agent
Sponsors: Chonnam National University Hospital
Not yet recruiting
May 01, 2026
Conditions: Atrial Fibrillation (AF); Heart Failure; Cardiomyopathies
Interventions: Device: Left Bundle Branch Area Pacing (LBBAP) for CRT; Device: Coronary Sinus (CS) Lead-Based Biventricular CRT
Sponsors: Yonsei University
Not yet recruiting
May 01, 2026
Conditions: Type 2 Diabetes Mellitus; Hypertension; Autonomic Nervous System Diseases
Interventions: Dietary Supplement: Beetroot juice; Dietary Supplement: Nitrate-depleted Beetroot Juice Placebo
Sponsors: Oxford Brookes University
Not yet recruiting
May 01, 2026
Conditions: Cardiac Amyloidosis
Interventions: Drug: [64Cu]FBP8 PET/MR
Sponsors: Brigham and Women's Hospital
Recruiting
May 01, 2026
Conditions: Multiple Sclerosis; Depression - Major Depressive Disorder; Fatigue
Interventions: Device: Repetitive Transcranial Magnetic Stimulation (rTMS)
Sponsors: University of Calgary; Hotchkiss Brain Institute, University of Calgary
Not yet recruiting
May 01, 2026
Conditions: Spinal Cord Injuries (Complete and Incomplete)
Interventions: Device: Transauricular vagus nerve stimulation
Sponsors: University of Alabama at Birmingham
Not yet recruiting
May 01, 2026
Conditions: Atrial Fibrillation (AF)
Interventions: Device: Atrial Fibrillation Radiofrequency Ablation Only
Sponsors: Maxime Zabern
Not yet recruiting
April 30, 2026
Conditions: Malaria (Plasmodium Falciparum)
Interventions: Biological: PfSPZ Challenge (NF54); Device: Wearable Biosensor Devices; Other: Placebo
Sponsors: University of Maryland, Baltimore; Bill and Melinda Gates Foundation; Sanaria Inc.; University of Texas at Austin
Not yet recruiting
April 30, 2026
Conditions: Irritability; Neurodevelopmental Disorders; Impulsivity; Emotional Dysregulation; Distress, Emotional; Distress, Psychological
Interventions: Behavioral: AGENCIA Digital Self-Guided; Behavioral: AGENCIA In-person With Digital Assistant
Sponsors: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla; Hospitales Universitarios Virgen del Rocío; Instituto de Salud Carlos III
Not yet recruiting
April 30, 2026
Conditions: Tracheostomized Patients; Mechanical Ventilation Weaning; High Flow Oxygen Therapy
Interventions: Device: High-flow tracheal oxygen (HFTO); Device: Tracheal Mask (TM)
Sponsors: King Faisal Specialist Hospital & Research Center
Not yet recruiting
April 30, 2026
Conditions: Auscultation Training; Health Professions Education
Interventions: Behavioral: Traditional Auscultation Training; Behavioral: Ventriloscope Simulation Training
Sponsors: Youngstown State University
Not yet recruiting
April 30, 2026
Conditions: Heart Disease; Electrocardiograph; Echocardiography
Interventions: Diagnostic Test: echocardiography
Sponsors: The University of Hong Kong
Recruiting
April 30, 2026
Conditions: Endometriosis; Omics; Assisted Reproductive Technology
Sponsors: The Second Hospital of Shandong University
Active, not recruiting
April 30, 2026
Conditions: Prediabetes
Interventions: Drug: Chiglitazar sodium; Drug: Placebo
Sponsors: Second Xiangya Hospital of Central South University
Not yet recruiting
April 30, 2026
Conditions: Obsessive Compulsive Disorder (OCD)
Interventions: Device: Low Intensity Focused Ultrasound
Sponsors: University of Pennsylvania; Attune Neurosciences Inc
Recruiting
April 30, 2026
Conditions: Small Cell Lung Cancer (SCLC)
Interventions: Drug: IBI115
Sponsors: Innovent Biologics (Suzhou) Co. Ltd.
Not yet recruiting
April 30, 2026
Conditions: Preterm Premature Rupture of Membranes (PPROM); Premature Rupture of Membranes (PROM); High-Risk Pregnancy
Interventions: Behavioral: Emotional Freedom Technique (EFT); Behavioral: Music Therapy
Sponsors: Selcuk University
Not yet recruiting
April 30, 2026
Conditions: Pharmacokinetics; Pharmacodynamics; Insulin Aspart
Interventions: Drug: I004; Drug: NovoLog
Sponsors: Amphastar Pharmaceuticals, Inc.
Recruiting
April 30, 2026
Conditions: Type 2 Diabetes; Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)
Interventions: Drug: GLP-1 Receptor Agonists
Sponsors: The First Affiliated Hospital with Nanjing Medical University
Recruiting
April 30, 2026
Conditions: Non-communicable Diseases (NCD); Addiction to Opioids; Incarceration; Opioid-use Disorders
Sponsors: University of Thessaly; General Hospital of Trikala; General Hospital of Larissa; National Organization for the Prevention and Treatment of Addictions (EOPAE); 5th Regional Health Authority of Thessaly & Sterea; Correctional Facility (Prison) of Trikala; Region of Thessaly; University of Thessaly, Department of Nutrition and Dietetics
Recruiting
April 30, 2026
Conditions: Heart Failure
Interventions: Device: Renal denervation
Sponsors: Shanghai Golden Leaf MedTec Co. Ltd
Not yet recruiting
April 30, 2026
Conditions: Coronary Artery Disease
Sponsors: Emory University
Not yet recruiting
April 30, 2026
Conditions: Dyslipidemia
Interventions: Dietary Supplement: Halophyte plant extracts
Sponsors: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla; Joan Montaner Villalonga
Not yet recruiting
April 30, 2026
Conditions: Overweight; Obesity
Interventions: Behavioral: Short-term stair climbing exercise snack group; Behavioral: Long-duration stair climbing exercise snack group; Behavioral: Moderate-intensity continuous exercise(MICT)
Sponsors: Weifang Medical University
Not yet recruiting
April 30, 2026
Conditions: Venous Congestion; Heart Failure Acute; VExUS; Diuretics
Interventions: Other: Natriuresis-guided escalation of loop diuretics
Sponsors: University Hospital, Akershus; Ostfold Hospital Trust
Not yet recruiting
April 30, 2026
Conditions: Exocrine Pancreatic Insufficiency (EPI); Cystic Fibrosis (CF); Pancreatic Enzyme Abnormality; Pancreatic Diseases
Interventions: Drug: NHS7108; Drug: Zenpep®
Sponsors: Aimmune Nestlé Health Science US R&D, LLC; Parexel
Not yet recruiting
April 30, 2026
Conditions: Long COVID; Angina (Stable); INOCA (Ischemia With Non Obstructive Coronary Artery Disease); Chronic Coronary Syndrome
Interventions: Diagnostic Test: Coronary functional test
Sponsors: Fundacion Investigacion Interhospitalaria Cardiovascular
Active, not recruiting
April 29, 2026
Conditions: Sound Exposure; Exercise Performance
Interventions: Behavioral: High-Level Headphone Sound Exposure; Behavioral: No-Sound Headphone Condition
Sponsors: Saglik Bilimleri Universitesi
Not yet recruiting
April 29, 2026
Conditions: Transcatheter Aortic Valve Replacement (TAVR); Aortic Valve Stenosis
Interventions: Drug: Propofol; Drug: Dexmedetomidine; Drug: Midazolam; Drug: Fentanyl
Sponsors: David Lyubashevsky
Recruiting
April 29, 2026
Conditions: Obstructive Hypertrophic Cardiomyopathy (oHCM)
Interventions: Drug: Mavacamten
Sponsors: Bristol-Myers Squibb
Recruiting
April 29, 2026
Conditions: Pediatric Heart Failure; Congenital Heart Disease (CHD); Acquired Heart Disease; Pulmonary Hypertension; Post Cardiac Surgery
Interventions: Device: MedlyPeds App
Sponsors: The Hospital for Sick Children; University Health Network, Toronto
Not yet recruiting
April 29, 2026
Conditions: Obstructive Sleep Apnea (OSA); Sleep Apnea Syndrome, Obstructive; Heart Failure
Interventions: Drug: Empagliflozin; Device: Continuous Positive Airway Pressure (CPAP)
Sponsors: Medical University of Bialystok
Completed
April 29, 2026
Conditions: Urolithiasis; Airway Management
Interventions: Device: Videolaryngoscope; Device: VideoLMA
Sponsors: Ela Erdem Hıdiroglu
Not yet recruiting
April 29, 2026
Conditions: Multiple Myeloma
Interventions: Drug: Cevostamab; Drug: Pomalidomide; Drug: Dexamethasone; Drug: Daratumumab; Drug: Elotuzumab; Drug: Carfilzomib
Sponsors: Hoffmann-La Roche
Not yet recruiting
April 29, 2026
Conditions: Obstructive Sleep Apnea (OSA); Insomnia Chronic
Interventions: Behavioral: digital CBT-I; Device: CPAP
Sponsors: Centre Hospitalier Universitaire Vaudois
Not yet recruiting
April 29, 2026
Conditions: Diabete Type 2; Cardio Vascular Disease
Sponsors: Weill Cornell Medical College in Qatar; Hamad Medical Corporation
Recruiting
April 29, 2026
Conditions: Hypertension; Hemodynamic Response; Anesthesia
Interventions: Drug: Dexmedetomidine; Other: Normal Saline
Sponsors: Sindh Institute of Urology and Transplantation
Completed
April 29, 2026
Conditions: Reperfusion Injury; Post Cardiac Arrest Brain Injury
Interventions: Device: LUTICIA - Light Utilization COX-Inhibitory Device)
Sponsors: Mitovation, Inc; National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke (NINDS)
Not yet recruiting
April 29, 2026
Conditions: Sedation; Cataract; Hemodynamic; Hemodynamic Changes; Dexmedetomidine; Propofol Dosage; Fentanyl; Bradycardia; Tachycardia; Nausea and Vomiting
Interventions: Drug: Dexmedetomidine (DEX); Drug: Propofol (PRO); Drug: Fentanyl (FEN)
Sponsors: Saint-Joseph University
Recruiting
April 29, 2026
Conditions: Heart Failure With Reduced Ejection Fraction (HFrEF)
Interventions: Other: cardiac MRI; Other: Functional Testing
Sponsors: Heinrich-Heine University, Duesseldorf
Not yet recruiting
April 29, 2026
Conditions: Cardiovascular Health During Prolonged Sitting
Interventions: Dietary Supplement: dark chocolate; Dietary Supplement: Milk Chocolate; Dietary Supplement: White Chocolate
Sponsors: King Saud University
Recruiting
April 29, 2026
Conditions: Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Interventions: Device: Luscii
Sponsors: Bayer
Not yet recruiting
April 29, 2026
Conditions: PARKINSON DISEASE (Disorder)
Interventions: Device: transcutaneous auricular vagus nerve stimulation
Sponsors: University of Alabama at Birmingham
Recruiting
April 29, 2026
Conditions: Heart Failure
Interventions: Device: XVIVO Heart Assist Transport System
Sponsors: XVIVO Perfusion
Recruiting
April 28, 2026
Conditions: Rheumatoid Arthritis; Major Adverse Cardiac Events
Interventions: Drug: Tofacitinib 5 MG
Sponsors: Shaikh Zayed Hospital, Lahore
Recruiting
April 28, 2026
Conditions: Spinal Cord Injuries (SCI)
Interventions: Behavioral: High-intensity Rehabilitation; Behavioral: Usual Care
Sponsors: University of Alberta; Alberta Paraplegic foundation
Not yet recruiting
April 28, 2026
Conditions: Cardiometabolic Diseases; Insomnia Disorder
Interventions: Device: Auricular Acupuncture Therapy; Device: Sham Auricular Acupuncture Group
Sponsors: Jiangsu Taizhou People's Hospital
Not yet recruiting
April 28, 2026
Conditions: Long COVID
Interventions: Device: Telehealth exercise training program; Behavioral: Education and self-exercise
Sponsors: Tri-Service General Hospital
Completed
April 28, 2026
Conditions: Lung Carcinoma
Interventions: Procedure: Accelerometry; Other: Aerobic Exercise; Procedure: Biospecimen Collection; Other: Educational Intervention; Other: Electronic Health Record Review; Other: Physical Performance Testing; Procedure: Respiratory Muscle Training; Other: Supportive Care; Other: Survey Administration
Sponsors: Roswell Park Cancer Institute
Not yet recruiting
April 28, 2026
Conditions: Parkinsonism; REM Sleep Behavior Disorder
Sponsors: Ruijin Hospital
Recruiting
April 28, 2026
Conditions: Supraventricular Tachycardia; Supraventricular Tachycardias; Supraventricular Arrhythmia; SVT; PSVT
Interventions: Drug: Single-syringe Adenosine; Drug: Double Syringe Adenosine
Sponsors: Hormozgan University of Medical Sciences
Completed
April 28, 2026
Conditions: Breast Cancer; Breast - Female; Breast Cancer Females
Interventions: Behavioral: Dance Program Group
Sponsors: Federal University of Maranhao
Active, not recruiting
April 28, 2026
Conditions: Cirrhosis; Portal Hypertension
Interventions: Other: 4D-Flow Liver and heart MRI with Gadolinium injection; Biological: Samples Without DNA
Sponsors: Assistance Publique - Hôpitaux de Paris; Sorbonne University; Institute of Cardiometabolism and Nutrition, France
Not yet recruiting
April 28, 2026
Conditions: Chronic Kidney Disease; Type 2 Diabetes Mellitus
Interventions: Drug: Finerenone (Kerendia, BAY94-8862)
Sponsors: Bayer
Not yet recruiting